We deploy long-term capital, resources, and expertise to support innovative life science companies as they address unmet medical needs and improve the quality of life of patients around the world.
We make investments across equity and debt outside traditional categories and asset classes and aim to build a concentrated, global portfolio of investments across high conviction themes including decarbonization, cleantech, and industrial automation.
Founded in 2015 to enable the coming electrification of everything, Group14's battery materials breakthrough brings new levels of energy performance to lithium-ion-powered devices and vehicles.
Founded in 2015 to enable the coming electrification of everything, Group14's battery materials breakthrough brings new levels of energy performance to lithium-ion-powered devices and vehicles.
BioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease.
BioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease.
AGP Group is one of the world’s leading glazing manufacturers. With around 3,000 employees from over 50 different nationalities, the company provides high-tech glazing solutions to more than 20 automotive brands that are shaping the future of mobility through electrification and autonomous driving.
AGP Group is one of the world’s leading glazing manufacturers. With around 3,000 employees from over 50 different nationalities, the company provides high-tech glazing solutions to more than 20 automotive brands that are shaping the future of mobility through electrification and autonomous driving.